Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 27.99
- Piotroski Score 2.00
- Grade Buy
- Symbol (ABL)
- Company Abacus Life, Inc.
- Price $8.95
- Changes Percentage (6.17%)
- Change $0.52
- Day Low $8.40
- Day High $9.21
- Year High $13.25
Abacus Life, Inc. operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 03/20/2025
- Fiscal Year End N/A
- Average Stock Price Target $13.50
- High Stock Price Target $15.00
- Low Stock Price Target $12.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.16
- Trailing P/E Ratio 64.88
- Forward P/E Ratio 64.88
- P/E Growth 64.88
- Net Income $9.52 M
Income Statement
Quarterly
Annual
Latest News of ABL
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Pittsburgh restaurant named one of the best in America by OpenTable
Morcilla in Pittsburgh's Lawrenceville neighborhood has been named one of the top 100 restaurants in America for 2024 by OpenTable. Known for Spanish-inspired dishes, it was chosen based on diner revi...
By CBS News | 6 hours ago -
Joyce's (ASX:JYC) investors will be pleased with their enviable 327% return over the last five years
Investing in stocks can lead to loss or significant gains. Joyce Corporation Ltd (ASX:JYC) has seen a 208% increase in five years, with consistent EPS growth at 21% annually....
By Yahoo! Finance | 9 hours ago -
Survival rates in UK for two lethal cancers lower than in comparable countries, research shows
A study by OECD revealed UK's poor outcomes for lung and colon cancer survival rates compared to other countries. Experts call for urgent action and a national cancer plan to improve care and reduce c...
By The Guardian | 14 hours ago
